MAD2L2 and cancer: We initially applied the gene expression profiling interactive analysis 2 (GEPIA2) to determine the expression of MAD2L2 in pan-cancer sample data (Fig. 1A) between tumor samples and paired normal tissue samples taken from the same patient.